Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Fan Chen
Observed name:
Chen, Fan
Institution:
Sun Yat-sen University Cancer Center
Observed institutions:
University of Kentucky,
Shandong University,
Sun Yat-sen University,
Sun Yat-sen University Cancer Center,
Qilu Hospital of Shandong University,
State Key Laboratory of Oncology in South China
show all 6
ORCID:
0000-0002-1808-1668
Observed ORCID:
0000-0002-1808-1668
OpenAlex ID:
A5100322103
EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
·
Cancer Research Communications
·
38
PDF
EZH2 inhibition confers PIK3CA-driven lung tumors enhanced sensitivity to PI3K inhibition
2021
·
Fan Chen
, Jinpeng Liu
, et al.
·
Cancer Letters
·
37
Cellular Origins of EGFR‐Driven Lung Cancer Cells Determine Sensitivity to Therapy
2021
·
Fan Chen
, Jinpeng Liu
, et al.
·
Advanced Science
·
32
PDF
Polycomb deficiency drives a FOXP2-high aggressive state targetable by epigenetic inhibitors
2023
·
Fan Chen
, Aria L. Byrd
, et al.
·
Nature Communications
·
24
PDF
Dysregulated Polycomb Repressive Complex 2 contributes to chronic obstructive pulmonary disease by rewiring stem cell fate
2022
·
Aria L. Byrd
, Xufeng Qu
, et al.
·
Stem Cell Reports
·
8
Ectopic Cushing’s syndrome due to retroperitoneal ACTH-producing paragangliomas
2016
·
Fan Chen
, Xiangyu Wang
, et al.
·
Canadian Urological Association Journal
·
5
PDF
Using 3-Dimensional Cultures to Propagate Genetically Modified Lung Organoids
2024
·
Fan Chen
, Kassandra J. Naughton
, et al.
·
Methods in molecular biology
·
3
Abstract 7189: EED inhibitor APG-5918 renders vulnerability to immunotherapy by rewiring sphingolipid metabolism via nSMase2-ceramide pathway in pancreatic cancer
2025
·
Jing Yang
, Fan Chen
, et al.
·
Cancer Research
·
1
Data from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
·
1
FIGURE 3 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
Supplementary Figure 4 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
Supplementary Figure 2 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
PDF
Supplementary Table 4 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
FIGURE 2 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
FIGURE 4 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
FIGURE 6 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
FIGURE 1 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
FIGURE 2 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
Supplementary Table 6 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
PDF
Supplementary Table 2 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
PDF
Supplementary Table 5 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
PDF
Supplementary Table 1 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
Supplementary Table 3 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
Supplementary Figure 3 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
Supplementary Figure 1 from EZH2 Inhibition Promotes Tumor Immunogenicity in Lung Squamous Cell Carcinomas
2024
·
Tanner J. DuCote
, Xiulong Song
, et al.
PDF
Show more works
View as search
Works count:
34
Citation count:
149
H-index:
5
I10-index:
4
Year
Topic
Type